2024
Erdheim–Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022
Sharma M, Stevens S, Maeng M, Nagornaya N, Bhatia R, Wester S. Erdheim–Chester Disease With Eyelid and Orbital Involvement: A Review of Treatment Modalities at One Institution From 2014 to 2022. Ophthalmic Plastic And Reconstructive Surgery 2024, 40: 497-503. PMID: 38427815, PMCID: PMC11377047, DOI: 10.1097/iop.0000000000002619.Peer-Reviewed Original ResearchErdheim-Chester diseaseBascom Palmer Eye InstituteEye InstituteOrbital involvementTreatment of Erdheim-Chester diseaseErdheim-Chester disease patientsCase of Erdheim-Chester diseaseIntolerable side effectsRetrospective chart reviewFavorable treatment optionRelevant laboratory resultsReview of treatmentOphthalmic examinationDry eyeOphthalmic symptomsReducing proptosisBRAF inhibitorsECD patientsPathology reportsOphthalmic institutionsOrbital diseaseChart reviewTreatment modalitiesErdheim-ChesterPrimary treatmentDisorders with Ophthalmic and Thoracic Involvement.
Gosangi B, Lang P, Johnson M, Zukerman R, Tu L, Traube L, Bader A, Rubinowitz A. Disorders with Ophthalmic and Thoracic Involvement. RadioGraphics 2024, 44: e230132. PMID: 38870047, DOI: 10.1148/rg.230132.Peer-Reviewed Original ResearchConceptsClinical manifestationsExamination of family membersEhlers-Danlos syndromeAffecting patient outcomesAcute sarcoidosisOphthalmologic examinationThoracic symptomsDry eyeThoracic involvementOphthalmological symptomsOphthalmologic manifestationsEye symptomsMarfan syndromeSjogren's syndromeImaging findingsRadiological studiesLung diseasePatient outcomesEhlers-DanlosFamily membersMultimodal imagingSystem conditionsSyndromeThoracicSarcoidosisA CXCR3-Activating Peptide Increases Tear Break Up Time and Corrects Corneal haze in a Rabbit Model of Environmental Dry Eye
Wells A, Wang Y, Shao H, Sohnen P, Swamynathan S. A CXCR3-Activating Peptide Increases Tear Break Up Time and Corrects Corneal haze in a Rabbit Model of Environmental Dry Eye. Journal Of Pharmacy And Pharmacology Research 2024, 8: 23-27. PMID: 38736523, PMCID: PMC11086663, DOI: 10.26502/fjppr.094.Peer-Reviewed Original ResearchDry eye diseaseCorneal hazeKeratoconjunctivitis siccaTear qualityDry eye disease casesTear break-up timeHuman conjunctival epithelial cellsBreak-up timeConjunctival epithelial cellsInjection of peptideNew Zealand white rabbitsCorneal inflammationIncreased goblet cell numbersSubconjunctival injectionCorneal pathologyDry eyeZealand white rabbitsActivates CXCR3Eye diseaseTear stabilityInflammatory stimuliChemical injuryEpithelial cellsInflammatory responseEyedrops
2023
Coexistent Sjogren’s syndrome and Birt-Hogg-Dube´ syndrome: a case report
Lin Y, Guo T, Lei C, Yang B, Yang D, Luo H, Peng H. Coexistent Sjogren’s syndrome and Birt-Hogg-Dube´ syndrome: a case report. BMC Pulmonary Medicine 2023, 23: 460. PMID: 37993820, PMCID: PMC10664354, DOI: 10.1186/s12890-023-02680-5.Peer-Reviewed Original ResearchConceptsSjogren's syndromeBirt-HoggMultiple thin-walled cystic lesionsDiffuse cystic lung diseasesThin-walled cystic lesionsShortness of breathCystic lung diseaseLabial gland biopsyDry eyeLower lungCystic changesCystic lesionsLung diseasePhysical examinationCase reportGland biopsyDube syndromeRare caseComputed tomographyDubé syndromeInsufficient evidenceSyndromeDiagnostic algorithmLungRespiratory sounds
2022
Microbiome and immune-mediated dry eye: a review
Watane A, Raolji S, Cavuoto K, Galor A. Microbiome and immune-mediated dry eye: a review. BMJ Open Ophthalmology 2022, 7: e000956. PMID: 36161855, PMCID: PMC9214397, DOI: 10.1136/bmjophth-2021-000956.Peer-Reviewed Original ResearchConceptsOcular surface microbiomeDry eyeAutoimmune diseasesFecal microbial transplantGut microbiome changesCertain autoimmune diseasesLymphocyte responsesMicrobial transplantTherapeutic strategiesImmune systemMicrobiome changesGut microbiomeDiseaseKey articlesEyesLess informationMicrobiome variesMicrobiome manipulationMicrobiomeSurface microbiomeReviewTransplantIndividualsSeverityDemographics
2021
Fecal Microbial Transplant in Individuals With Immune-Mediated Dry Eye
Watane A, Cavuoto K, Rojas M, Dermer H, Day J, Banerjee S, Galor A. Fecal Microbial Transplant in Individuals With Immune-Mediated Dry Eye. American Journal Of Ophthalmology 2021, 233: 90-100. PMID: 34214453, PMCID: PMC8678170, DOI: 10.1016/j.ajo.2021.06.022.Peer-Reviewed Original ResearchConceptsGut microbiome profilesT cell profileFecal microbial transplantDry eyeMicrobiome profilesMicrobial transplantDE symptomsRegulatory T-cell profilesDE symptom severityNonrandomized clinical trialPrimary outcome measureDonor microbiomeSingle healthy donorAdverse eventsMean ageClinical trialsHealthy donorsOutcome measuresStudy populationSymptom severityAdministration methodsBaseline profileGenus FaecalibacteriumTime pointsMonths
2020
Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis
Hong R, Xu D, Hsieh E, Xiang Y, Zhao J, Wang Q, Tian X, Li M, Zhao Y, Zeng X. Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis. Frontiers In Medicine 2020, 7: 614482. PMID: 33324667, PMCID: PMC7726424, DOI: 10.3389/fmed.2020.614482.Peer-Reviewed Original ResearchPrimary Sjögren's syndromeAnti-SSB antibodiesRenal involvementSjögren's syndromeLarge-scale prospective cohort studyLabial salivary gland biopsyAnti-SSA antibodiesChronic renal diseaseProspective cohort studyNewcastle-Ottawa ScaleFurther risk factorsSalivary gland biopsyOdds ratio valuesWeb of ScienceFixed-effects modelRenal impairmentCohort studyCritical complicationsDry eyePS patientsRenal diseaseRheumatoid factorCochrane LibraryRisk factorsGland biopsyOphthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016
Chen EM, Kombo N, Teng CC, Mruthyunjaya P, Nwanyanwu K, Parikh R. Ophthalmic Medication Expenditures and Out-of-Pocket Spending An Analysis of United States Prescriptions from 2007 through 2016. Ophthalmology 2020, 127: 1292-1302. PMID: 32359935, PMCID: PMC7508869, DOI: 10.1016/j.ophtha.2020.04.037.Peer-Reviewed Original ResearchConceptsOphthalmic medicationsMedication expendituresOOP expenditureLongitudinal cohort studyOverall drug expendituresUnited States populationPrescription drug spendingGlaucoma medicationsCohort studyMedication useDry eyePrescription usePrescription expendituresPrescription medicationsOOP expensesMedicationsCopayment assistancePocket expenditureOOP spendingDrug expendituresPocket spendingDrug spendingIndirect costsMEPS participantsLinear regressionGut microbial dysbiosis in individuals with Sjögren’s syndrome
Mendez R, Watane A, Farhangi M, Cavuoto KM, Leith T, Budree S, Galor A, Banerjee S. Gut microbial dysbiosis in individuals with Sjögren’s syndrome. Microbial Cell Factories 2020, 19: 90. PMID: 32293464, PMCID: PMC7158097, DOI: 10.1186/s12934-020-01348-7.Peer-Reviewed Original ResearchConceptsHealthy controlsDE symptomsFull criteriaGut microbiomeGut microbial dysbiosisDepletion of FirmicutesExpansion of ProteobacteriaDry eyeSjögren's syndromeMicrobial dysbiosisMicrobiome alterationsDE measuresConclusionsIn conclusionMicrobial compositionEye measuresSyndromeSymptomsSjögrenDifferential clusteringAssociationSignsIndividualsPrinciple co-ordinate analysisPhylum levelMicrobiome
2019
The Microbiome and Ocular Surface Disease
Watane A, Cavuoto K, Banerjee S, Galor A. The Microbiome and Ocular Surface Disease. Current Ophthalmology Reports 2019, 7: 196-203. DOI: 10.1007/s40135-019-00217-w.Peer-Reviewed Original Research
2016
Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease
Gupta P, Vora G, Matossian C, Kim M, Stinnett S. Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Canadian Journal Of Ophthalmology 2016, 51: 249-253. PMID: 27521662, DOI: 10.1016/j.jcjo.2016.01.005.Peer-Reviewed Original ResearchConceptsEvaporative dry eye diseaseOcular Surface Disease IndexDry eye diseaseMeibomian gland dysfunctionExamination findingsIPL therapyEye diseaseLight therapyDiagnosis of MGDIntense pulsed light therapyLid margin vascularityMulticentre cohort studyAdverse ocular effectsClinical examination findingsDuke Eye CenterPrivate practiceOSDI scoreCohort studyClinical outcomesDry eyeTear breakGland dysfunctionIntraocular pressureIPL sessionsOphthalmology clinicCyclosporine for Dry Eye Associated With Nivolumab
Nguyen AT, Elia M, Materin MA, Sznol M, Chow J. Cyclosporine for Dry Eye Associated With Nivolumab. Cornea 2016, 35: 399-401. PMID: 26771550, DOI: 10.1097/ico.0000000000000724.Peer-Reviewed Original ResearchConceptsDry eye diseaseMetastatic melanomaTopical cyclosporineCorneal perforationDry eyeEye diseaseSevere dry eye symptomsBilateral dry eyesDry Eye AssociatedOcular surface inflammationSevere dry eyeDry eye symptomsImprovement of symptomsNivolumab therapyIntensive regimenSurface inflammationEye symptomsMetastatic diseaseClinical outcomesAggressive lubricationRight eyeCase reportNivolumabOcular surfaceAntitumor effects
2015
Intense pulsed light therapy for the treatment of evaporative dry eye disease
Vora G, Gupta P. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Current Opinion In Ophthalmology 2015, 26: 314-318. PMID: 26058031, DOI: 10.1097/icu.0000000000000166.Peer-Reviewed Original ResearchConceptsDry eye diseaseEvaporative dry eye diseaseMeibomian gland dysfunctionEye diseaseOcular rosaceaDry eyeLight therapyChronic meibomian gland dysfunctionEvaporative dry eye patientsDry eye patientsDry eye symptomsClinical exam findingsChronic skin conditionEvaporative dry eyePersonal clinical experienceUse of IPLTopical cyclosporineOral doxycyclineEye patientsEye symptomsPatients' qualityWarm compressesExam findingsGland dysfunctionIPL therapy
2009
CORNEOSCLERAL NECROSIS AFTER EPISCLERAL AU-198 BRACHYTHERAPY OF UVEAL MELANOMA
CHAUDHRY I, LIU M, SHAMSI F, ARAT Y, SHETLAR D, BONIUK M. CORNEOSCLERAL NECROSIS AFTER EPISCLERAL AU-198 BRACHYTHERAPY OF UVEAL MELANOMA. Retina 2009, 29: 73-79. PMID: 18728617, DOI: 10.1097/iae.0b013e3181863f7c.Peer-Reviewed Original ResearchConceptsCiliary body involvementRisk factorsTumor thicknessDry eyeUveal melanomaBody involvementEvidence of recurrent tumorSymptoms of dry eyeComplaints of dry eyesClinical records of patientsIntraocular pressure >Au-198Close follow-upForeign body sensationRecords of patientsAssociated risk factorsCiliochoroidal melanomaPrimary choroidalRadioactive plaquesRecurrent tumorsConjunctival flapIntraocular pressureScleral patchLevel of statistical significanceFailed treatment
2007
Effect of Botulinum Toxin Type A on Tear Production After Treatment of Lateral Canthal Rhytids
Arat Y, Yen M. Effect of Botulinum Toxin Type A on Tear Production After Treatment of Lateral Canthal Rhytids. Ophthalmic Plastic And Reconstructive Surgery 2007, 23: 22-24. PMID: 17237684, DOI: 10.1097/iop.0b013e31802dfca7.Peer-Reviewed Original ResearchConceptsSchirmer test resultsLateral canthal rhytidsTear productionBotulinum toxin type ADry eyeToxin type ATreatment of lateral canthal rhytidsFollow-upSchirmer 1 testUnits of botulinum toxinDry-eye symptomsDecreased tear productionBotulinum toxinCrow's feet areasMonths follow-upBotulinum toxin type A injectionBotulinum toxin injectionEffect of botulinum toxin type ADry-eyeType ASchirmerPatientsToxin injectionCrow's-feetStatistical difference
2006
The effect of Gonioscopy on keratometry and corneal surface topography
George MK, Kuriakose T, DeBroff BM, Emerson JW. The effect of Gonioscopy on keratometry and corneal surface topography. BMC Ophthalmology 2006, 6: 26. PMID: 16780595, PMCID: PMC1550259, DOI: 10.1186/1471-2415-6-26.Peer-Reviewed Original ResearchConceptsSim KCentral corneal surfaceIntraocular lens implantsConnective tissue disordersYears of ageSignificant differencesSRK II formulaCorneal curvature measurementsCorneal topography measurementsCorneal surface topographyDry eyeOcular surgeryApplanation tonometryIntraocular lensLens implantsTissue disordersCorneal curvatureSimulated keratometryExclusion criteriaGonioscopyK readingsGonioscopeShort-term effectsBaseline measurementsCorneal surface
2002
A Case of Bronchus-Associated Lymphoid Tissue(BALT) Lymphoma in the Lung of the Patient with Primary Sjogren's Syndrome
Kang M, Lee J, Lee S, Son J, Kim D, Lee M, Hyun I, Jung K. A Case of Bronchus-Associated Lymphoid Tissue(BALT) Lymphoma in the Lung of the Patient with Primary Sjogren's Syndrome. Tuberculosis And Respiratory Diseases 2002, 52: 179-185. DOI: 10.4046/trd.2002.52.2.179.Peer-Reviewed Original ResearchPrimary Sjogren's syndromeSjogren's syndromeOpen lung biopsy specimenB-cell lymphoma originatingThin-section CT scansCD 20 antigenAnti-nuclear antibodiesWhole lung fieldMalignant lymphoma cellsBALT lymphomaInspiratory cracklesReticulonodular densitiesDry mouthExertional dyspneaLymphoma originatingDry eyeHistological diagnosisHistological findingsLung zonesPhysical examinationBasal lungBiopsy specimenBronchiolar epitheliumChest radiographsLung fields
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply